Clinical trial

Open-Label Dose-Ranging Study of Oral SM-001 in Healthy Adults

NCT05894902

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention SM-001 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Open-Label Dose-Ranging Study of Oral SM-001 in Healthy Adults

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-10-01

PhasePHASE1

Conditions

Major Depressionverified · MONDO: major depressive disorder

Post Traumatic Stress Disordercandidate · MONDO: post-traumatic stress disorder

Interventions

SM-001DRUG

Sponsors & collaborators

Advanced Integrative Medical Science Institutelead sponsor

Mapped research locations

SeattleWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05894902 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.